Gain-of-function miRNA signature by mutant p53 associates with poor cancer outcome

Bond, 2015, Interaction between p53 mutation and a somatic HDMX biomarker better defines metastatic potential in breast cancer, Cancer research, 75, 698, 10.1158/0008-5472.CAN-14-2637

Xu, 2013, The gain of function of p53 cancer mutant in promoting mammary tumorigenesis, Oncogene, 32, 2900, 10.1038/onc.2012.299

Blagosklonny, 2002, P53: an ubiquitous target of anticancer drugs, International journal of cancer, 98, 161, 10.1002/ijc.10158

Kim, 2006, AIMP3 haploinsufficiency disrupts oncogene-induced p53 activation and genomic stability, Cancer research, 66, 6913, 10.1158/0008-5472.CAN-05-3740

Fang, 2013, RhoGAPs attenuate cell proliferation by direct interaction with p53 tetramerization domain, Cell reports, 3, 1526, 10.1016/j.celrep.2013.04.017

Vousden, 2006, TIGAR, a p53-inducible regulator of glycolysis and apoptosis, Cell, 126, 107, 10.1016/j.cell.2006.05.036

He, 2013, Cardiomyocyte-expressed farnesoid-X-receptor is a novel apoptosis mediator and contributes to myocardial ischaemia/reperfusion injury, Eur Heart J, 34, 1834, 10.1093/eurheartj/ehs011

Blagosklonny, 2000, p53 from complexity to simplicity: mutant p53 stabilization, gain-of-function, and dominant-negative effect, The FASEB Journal, 14, 1901, 10.1096/fj.99-1078rev

Lozano, 2004, Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome, Cell, 119, 861, 10.1016/j.cell.2004.11.006

Blagosklonny, 2005, Complementation of two mutant p53: Implications for loss of heterozygosity in cancer, FEBS letters, 579, 2231, 10.1016/j.febslet.2005.03.012

Fang, 2014, Heterogeneity of Li-Fraumeni syndrome links to unequal gain-of-function effects of p53 mutations, Scientific reports, 4, 4223, 10.1038/srep04223

Prives, 2012, Mutant p53: one name, many proteins, Genes & development, 26, 1268, 10.1101/gad.190678.112

Daggett, 2011, Structural effects of the L145Q, V157F, and R282W cancer-associated mutations in the p53 DNA-binding core domain, Biochemistry, 50, 5345, 10.1021/bi200192j

Rousseau, 2011, Gain of function of mutant p53 by coaggregation with multiple tumor suppressors, Nature chemical biology, 7, 285, 10.1038/nchembio.546

Fang, 2014, Unequal prognostic potentials of p53 gain-of-function mutations in human cancers associate with drug-metabolizing activity, Cell death & disease, 5, e1108, 10.1038/cddis.2014.75

Fang, 2013, Candidate microRNA biomarkers in human gastric cancer: a systematic review and validation study, PloS one, 8, e73683, 10.18632/oncotarget.3005

Liu, 2010, An in silico analysis of microRNAs: mining the miRNAome, Molecular bioSystems, 6, 1853, 10.1039/c003961f

Chen, 2015, Identification of a microRNA signature associated with risk of distant metastasis in nasopharyngeal carcinoma, Oncotarget, 6, 4537, 10.18632/oncotarget.3005

Xu, 2015, A radiosensitivity MiRNA signature validated by the TCGA database for head and neck squamous cell carcinomas, Oncotarget, 6, 34649, 10.18632/oncotarget.5299

Meller, 2014, TRPM3 and miR-204 establish a regulatory circuit that controls oncogenic autophagy in clear cell renal cell carcinoma, Cancer cell, 26, 738, 10.1016/j.ccell.2014.09.015

Sumani, 2014, MicroRNA-135b promotes cancer progression by acting as a downstream effector of oncogenic pathways in colon cancer, Cancer cell, 25, 469, 10.1016/j.ccr.2014.03.006

Fang, 2015, Roles of competing endogenous RNAs in gastric cancer, Briefings in functional genomics

Guo, 2014, Long noncoding RNA associated-competing endogenous RNAs in gastric cancer, Scientific reports, 4, 6088, 10.1038/srep06088

Xu, 2015, Gastric cancer and gene copy number variation: emerging cancer drivers for targeted therapy, Oncogene

Xu, 2015, Somatic gene copy number alterations in colorectal cancer: new quest for cancer drivers and biomarkers, Oncogene

Hermeking, 2012, MicroRNAs in the p53 network: micromanagement of tumour suppression, Nature Reviews Cancer, 12, 613, 10.1038/nrc3318

Fang, 2014, Long noncoding RNA GAPLINC regulates CD44-dependent cell invasiveness and associates with poor prognosis of gastric cancer, Cancer research, 74, 6890, 10.1158/0008-5472.CAN-14-0686

Gomes, 2015, Functional and molecular characterization of cancer stem-like cells in bladder cancer: a potential signature for muscle-invasive tumors, Oncotarget, 6, 36185, 10.18632/oncotarget.5517

Caudell, 2015, The radiosensitivity index predicts for overall survival in glioblastoma, Oncotarget, 6, 34414, 10.18632/oncotarget.5437

Xu, 2006, Rat toxicogenomic study reveals analytical consistency across microarray platforms, Nat Biotechnol, 24, 1162, 10.1038/nbt1238

The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nat Biotechnol. 2006; 24:1151–1161.

Bao, 2008, The balance of reproducibility, sensitivity, and specificity of lists of differentially expressed genes in microarray studies, BMC Bioinformatics, 9, S10, 10.1186/1471-2105-9-S9-S10

Marincola, 2010, MicroRNA expression differentiates histology and predicts survival of lung cancer, Clinical Cancer Research, 16, 430, 10.1158/1078-0432.CCR-09-1736

Lee, 2003, Local-pooled-error test for identifying differentially expressed genes with a small number of replicated microarrays, Bioinformatics, 19, 1945, 10.1093/bioinformatics/btg264

Liu, 2010, A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer, PloS one, 5, e13735, 10.1371/journal.pone.0013735

Remaley, 2011, MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins, Nature cell biology, 13, 423, 10.1038/ncb2210

Hermeking, 2015, p53-Regulated Networks of Protein, mRNA, miRNA, and lncRNA Expression Revealed by Integrated Pulsed Stable Isotope Labeling With Amino Acids in Cell Culture (pSILAC) and Next Generation Sequencing (NGS) Analyses, Molecular & cellular proteomics, 14, 2609, 10.1074/mcp.M115.050237

Cancer Genome Atlas Research N, 2014, Comprehensive molecular characterization of gastric adenocarcinoma, Nature, 513, 202, 10.1038/nature13480

Fang, 2014, Long noncoding RNA profiles identify five distinct molecular subtypes of colorectal cancer with clinical relevance, Molecular oncology, 8, 1393, 10.1016/j.molonc.2014.05.010

Ragoussis, 2011, microRNA-associated progression pathways and potential therapeutic targets identified by integrated mRNA and microRNA expression profiling in breast cancer, Cancer research, 71, 5635, 10.1158/0008-5472.CAN-11-0489

Hatzigeorgiou, 2015, DIANA-miRPath v3. 0: deciphering microRNA function with experimental support, Nucleic acids research, 43, W460, 10.1093/nar/gkv403

Camargo, 2013, The hippo tumor suppressor network: from organ size control to stem cells and cancer, Cancer research, 73, 6389, 10.1158/0008-5472.CAN-13-2392

Nagase, 2015, Hippo and TGF-beta interplay in the lung field. American journal of physiology Lung cellular and molecular physiology, Am J Physiol Lung Cell Mol Physiol, 309, L756, 10.1152/ajplung.00238.2015

Mullen, 2014, Hippo tips the TGF-beta scale in favor of pluripotency, Cell stem cell, 14, 6, 10.1016/j.stem.2013.12.009

Van Maerken, 2015, Genome wide expression profiling of p53 regulated miRNAs in neuroblastoma, Scientific reports, 5, 9027, 10.1038/srep09027

Castellano, 2013, The p53 miRNA interactome and its potential role in the cancer clinic, Epigenomics, 5, 417, 10.2217/epi.13.41

Mizutani, 2012, Analysis of p53 and miRNA expression after irradiation of glioblastoma cell lines, Anticancer research, 32, 4709

Landi, 2013, More targets, more pathways and more clues for mutant p53, Oncogenesis, 2, e54, 10.1038/oncsis.2013.15

Pan, 2015, YAPing Hippo Forecasts a New Target for Lung Cancer Prevention and Treatment, Journal of clinical oncology, 33, 2311, 10.1200/JCO.2015.61.2093

Sudo, 2014, Hippo coactivator YAP1 upregulates SOX9 and endows esophageal cancer cells with stem-like properties, Cancer research, 74, 4170, 10.1158/0008-5472.CAN-13-3569

Kim, 2011, Comprehensive evaluation of matrix factorization methods for the analysis of DNA microarray gene expression data, BMC bioinformatics, 12, S8, 10.1186/1471-2105-12-S13-S8

Yeung, 2008, MeV+R: using MeV as a graphical user interface for Bioconductor applications in microarray analysis, Genome biology, 9, R118, 10.1186/gb-2008-9-7-r118